About VicalVical researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. In addition,pplications of the company DNA delivery technology include DNA vaccines against infectious diseases or cancer, wherein the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein stimulating an immune system, in which cardiovascular, in which the expressed protein is an angiogenic growth factor.
The DSMB evaluated safety data sheets only in the interim analysis.
Conducted FDA approval of new device-based method for asthma severityAsthmatx, a medical device company that has developed a catheter-based procedure for the treatment of severe asthma, announced today that it filed its Pre-Market Approval application for the Alair Bronchial thermoplasty system with the U.S. Food and Drug Administration . In addition the Company announced that the FDA has granted Expedited Review status of the Alair System. Bronchial thermoplasty with the Alair System is an investigational procedure that can the standard of care for millions of asthma change..Continue Reading